News and Trends 9 Mar 2023
Iktos raises €15.5M to expand AI drug discovery technologies
Iktos, a company specializing in artificial intelligence (AI) for new drug discovery, has closed a €15.5 million ($16.4 million) Series A…
France
- Latest Posts
News and Trends 14 Feb 2023
BiPER Therapeutics raises €1.25M to develop small molecules to treat gastrointestinal cancers
BiPER Therapeutics, a French preclinical biotechnology company developing first-in-class drug candidates targeting BiP protein to treat gastrointestinal cancers, has raised…
News and Trends 7 Feb 2023
Mnemo Therapeutics and Institut Curie studies lead to cancer-specific targets
Mnemo Therapeutics, a French biotechnology company developing immunotherapies, has announced publication of two scientific studies developed at Institut Curie, its…
News and Trends 27 Jan 2023
Onxeo to study prostate cancer drug
French biotech company Onxeo S.A. has given an update on the clinical development program of its first-in-class drug candidate AsiDNA.…
ADVERTISEMENT
News and Trends 24 Jan 2023
First leukemia patient dosed with SMART101
Smart Immune has announced that the first adult leukemia patient has been dosed with SMART101, a T-cell progenitor cell injection…
News and Trends 9 Jan 2023
ErVaccine raises €4.5M to start therapeutic cancer vaccine trial
ErVaccine Technologies, announces the closing of a €4.5 million ($4.8 million) seed round, including dilutive and non-dilutive funds, with Seventure…
News and Trends 6 Jan 2023
Transgene approved for IV oncolytic virus trial
Transgene has received clinical trial application (CTA) approval from the French National Agency for the Safety of Medicines and Health…
News and Trends 3 Jan 2023
Sensorion announces first patient enrolled in cisplatin-induced ototoxicity trial
Sensorion has announced that the first patient has been enrolled in its phase 2a proof of concept clinical trial of…
News and Trends 1 Jan 2023
Watch: Addressing IP with Starting Bloch
Starting Bloch is a French-headquartered company helping companies navigate the world of IP and patents. The company’s Patman platform was…
Startup Scout 13 Dec 2022
Biomemory is making DNA hard drives cheap and sustainable
The world is running out of ways to store the mountains of data we produce. Biomemory is creating DNA-based hard…
ADVERTISEMENT
News and Trends 12 Dec 2022
Enterome completes patient enrollment for recurrent glioblastoma study
Enterome has completed patient enrollment in its phase 2 clinical trial (ROSALIE) evaluating its lead OncoMimics candidate, EO2401, in combination…
News and Trends 9 Dec 2022
Beyond Biotech podcast 25: Center for Global Development, Humacyte, Transgene
This week, we have three interviews. One is from Bio-Europe, a chat with Transgene chief business officer, Steven Bloom, and…
News and Trends 7 Dec 2022
Touchlight and Odimma Therapeutics sign deal to develop personalized cancer therapy
Touchlight, a biotechnology company pioneering enzymatic DNA production to enable genetic medicines, has signed a development and supply agreement with…
News and Trends 7 Dec 2022
FDA clears insulin pen medical device
BIOCORP, a French company specialized in the design, development, and manufacturing of innovative medical devices, has received 510(K) clearance from…
Interview 29 Nov 2022
LAG-3: The next big checkpoint inhibitor target
Since their first approval a decade ago, immune checkpoint inhibitors have been gaining momentum in the treatment of cancer. The…
News and Trends 28 Nov 2022
Localizing BRCA gene mutations to better treat ovarian cancer
Mutations of BRCA1 and BRCA2 genes, which are inherited by 1 in 400 and 1 in 800 people respectively, significantly…
ADVERTISEMENT
News and Trends 28 Nov 2022
Biomemory raises €5M to advance DNA digital data storage solution
Biomemory, a start-up focused on DNA data synthesis and storage, has closed a €5 million ($5.2 million) seed investment for…
News and Trends 23 Nov 2022
Trial to start for new heart attack drug
A potential new drug to improve the long-term outcomes for heart attack patients will be trialed in the U.K. With…
Startup Scout 21 Nov 2022
Osivax is designing future-proof influenza and Covid vaccines
Viruses causing influenza and COVID-19 continually evolve to escape our vaccine protections. The French firm Osivax is developing vaccines that…
News and Trends 15 Nov 2022
Aelis Farma’s first trial for cognitive disorder drug for Down Syndrome patients
Aelis Farma has announced positive results from its safety trials in healthy volunteers and the authorization to start the first…